[1] Lu FM,Zhuang H.Management of hepatitis B in China[J].Chin Med J(Eng1),2009,122(1):3-4.
[2] Wang FS,Fan JG,Zhang Z,et al.The global burden of liver disease:the major impact of China[J].Hepatology, 2014,60(6):2099-2018.
[3] 郭振英,张爱霞,曹伯良.GP73在肿瘤诊断中的研究进展[J].中华检验医学杂志,2010,33(5):469-471.
[4] 黎晓武,李金强,罗向波,等.血清GP73、HSP27联合AFP检测在HBV相关早期肝细胞癌诊断的价值[J].实用预防医学,2016,23(11):1319-1321.
[5] 黄风玲,杨颖,张瑞丽,等.肝细胞癌组织中高尔基体蛋白73和转化生长因子β1及Smad2的表达水平及其意义[J].中国全科医学,2016,19(26):3191-3195.
[6] 中华医学会肝脏病学会.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2015,23(12):321-340.
[7] 和海玉,路明亮,黄华,等.GP73在慢性乙型肝炎、肝硬化、原发性肝癌血清及组织中的表达[J].昆明医科大学学报,2016,37(4):41-44.
[8] Hou SC,Xiao MB,Ni RZ,et al.Serum GP73 is complementary to AFP and GGT-Ⅱ for the diagnosis of hepatocellular cancinama[J].Oncol Lett,2013,6(4):1152-1158.
[9] Jing JS,Ye W,Jiang YK,et al.The value of GPC3 and GP73 inclinicaldiagnosis ofhepatocellularcarcinoma[J].Clin Lab,2017,63(11):1903-1909.
[10] 黄飞,贺新祥,刘文俊,等.Ⅱ型高尔基体膜蛋白73在肝细胞肝癌中的水平及与肝细胞肝癌预后的相关性[J].实用预防医学,2017,24(7):882-885.
[11] Kladney RD,Cui X,Bulla GA,et al.Expression of GP73,a resident Golgi membrane protein in viral and nonviral liver disease[J].Hepatology,2002,35(6):1431-1440.
[12] Iftikhar R,Kladney RD,Havliogu N,et al.Disease and cell specific expression of GP73 in human liver disease[J].Am J Gastroenterol,2004,99(6):1087-1095.
[13] Maitra A,Thuluvath PJ.GP73 and liver disease:a (Golgi) complexenigma[J].Am J Gastroenterol,2004,99(6):1096-1098.
[14] 乐萍,高国生,董飞波,等.血清高尔基体蛋白73及3种评分系统对慢性乙型肝炎患者肝纤维化的预测价值研究[J].中华医院感染学杂志,2016,26(11):2529-2532.
[15] 魏梅娟,张小曼,许正锯,等.慢性乙型肝炎患者抗病毒治疗前高尔基体蛋白73与细胞因子的相关性[J].中华实验和临床感染病杂志(电子版),2017,11(2):141-145.
[16] 彭桦,马薇,何前进,等.HBV激活Notch1信号通路上调GP73的表达[J].现代肿瘤医学,2017,25(22):3551-3554.
[17] 王翠,魏从文,邹德勇,等.高尔基蛋白73参与炎症反应的分子机制研究[J].军事医学,2016,40(4):304-307.